May 9, 2026

Ozempic

Centre warns pharma companies against promoting weight-loss drugs among public through ads – The Times of India

Centre warns pharma companies against promoting weight-loss drugs among public through ads – The Times of India

admin03 mins

NEW DELHI: The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs – popularly sold under brand names Ozempic, Wegovy and Mounjaro – through advertisements or “disease awareness” campaigns that indirectly encourage their use among the public.In an advisory, Central Drugs Standard Control Organisation said it had come to its notice that some…

Read More
When cost stops being the barrier: The new chapter of Ozempic injection in India | India News – The Times of India

When cost stops being the barrier: The new chapter of Ozempic injection in India | India News – The Times of India

admin015 mins

On most evenings at a diabetes clinic, the conversation eventually circles back to the same word: cost. Not calories, not carb counts, cost. For many patients, medicines like Ozempic have hovered in that uncomfortable space between medical breakthrough and financial capacity. Doctors spoke of their benefits with measured optimism; patients listened, did the math, and…

Read More
Oprah Winfrey Weight Loss: Oprah Winfrey’s slim look at Paris Fashion Week sparks talk about GLP-1 weight loss | English Movie News – The Times of India

Oprah Winfrey Weight Loss: Oprah Winfrey’s slim look at Paris Fashion Week sparks talk about GLP-1 weight loss | English Movie News – The Times of India

admin05 mins

Oprah Winfrey turned heads at Paris Fashion Week with her stunning new look, featuring a noticeably slimmer silhouette that has set social media abuzz. Her remarkable transformation, linked to GLP-1 medications such as Ozempic, has reignited debates surrounding celebrity weight loss journeys and the impact of cosmetic enhancements, captivating fans and critics alike across the…

Read More
The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline | – The Times of India

The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline | – The Times of India

admin09 mins

Some revolutions don’t start with flags or hashtags. They start with a needle. No this isn’t a Danny Boyle reference to Trainspotting, the heroin classic that was cinematic perfection before Ewan McGregor graduated to become Obi-Wan Kenobi. But, America’s latest cultural export isn’t a Marvel sequel or a TikTok trend — it’s a syringe. Across…

Read More
‘I’m in the public eye…’: Bhumi Pednekar talks about coping with body image issues and dealing with trolls | – The Times of India

‘I’m in the public eye…’: Bhumi Pednekar talks about coping with body image issues and dealing with trolls | – The Times of India

admin04 mins

Actress Bhumi Pednekar shared her journey of coping with body image issues and trolls, emphasizing the importance of self-love and a balanced approach to physical and mental health. She revealed that while she still faces difficult days, her routine helps her stay grounded, and she prioritizes her well-being over public opinion. Bhumi Pednekar recently opened…

Read More
Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks | – The Times of India

Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks | – The Times of India

admin05 mins

India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic’s arrival…

Read More
Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments – The Times of India

Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments – The Times of India

admin03 mins

Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to reduce its global workforce by 11 percent, eliminating 9,000 positions, including 5,000 in Denmark. The move aims to save eight billion kroner ($1.3 billion) as competition intensifies for its anti-obesity treatments Ozempic and Wegovy, as reported by AFP.The company also lowered its earnings forecast for…

Read More